TechNavio's analysts forecast the Global In Vitro Diagnostics (IVD) Products and Test market to grow at a CAGR of 4.33 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant growth of the IVD market in emerging countries. The market has also been witnessing a significant increase in the number of acquisitions of small and medium companies. However, the emergence of counterfeit or duplicate IVD products could pose a challenge to the growth of this market.

TechNavio's report, the Global IVD Products and Test Market - Strategic Volume and Pricing Analysis 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, F. Hoffmann-La Roche Ltd., and Siemens Healthcare.

The other vendors mentioned in the report are 23andMe Inc., A. Menarini Diagnostics S.r.l., Affymetrix Inc., Agilent Technologies Inc., Alere Inc., ARKRAY Inc., Arrayit Diagnostics Inc, Astra Biotech GmbH, Axis-Shield plc, Beckman Coulter Inc., BG Medicine Inc., Bio-Rad Laboratories Inc., Bruker BioSciences Corp., Caliper Life Sciences Inc., Celera Diagnostics LLC, Cepheid Inc., China Medical Technologies Inc., Dako A/S, Danaher Corp., DiaSorin S.p.A., Eiken Chemical Co. Ltd., ELITech SA, Enzo Biochem Inc., Epigenomics AG, Fujirebio Diagnostics Inc., GE Healthcare, Grifols SA, Horiba Ltd., Idaho Technology Inc., Illumina Inc., Innogenetics NV, Instrumentation Laboratory Company, International Technidyne Corp., Intrinsic Bioprobes Inc., IRIS International Inc., Life Technologies Corp., Linkage Biosciences Inc., Luminex Corp., Magellan Biosciences Inc., Millipore Corp., Mitsubishi Chemical Medience Corp., Nanosphere Inc., Nanosphere Inc., Nova Biomedical Corp., Novartis AG, OPTI Medical Systems Inc., OptiGene Ltd., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Phadia AB, Polymedco Inc., QIAGEN N.V., Quidel Corp., Radient Pharmaceuticals Corp., Radiometer A/S, Randox Laboratories Ltd., Seegene Inc., SensiGen LLC, Sequenom Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Spartan Bioscience Inc., Sysmex Corp., TessArae LLC, Thermo Fisher Scientific Inc., Tosoh Corp., Transasia Bio-Medicals Ltd., Transgenomic Inc., TrimGen Corp., Trinity Biotech plc, TrovaGene Inc., Ventana Medical Systems Inc., Veridex LLC, Vermillion Inc., Wako Pure Chemical Industries Ltd., and Werfen Life Group SA.

Key questions answered in this report:

What will the market size be in 2015 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.


Methodology

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Table Of Contents

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Global IVD Products and Test Market
Market Size
Market Forecast
06.2 Five Forces Analysis
07. Market Growth Drivers
08. Drivers and their Impact
09. Market Challenges
10. Impact of Drivers and Challenges
11. Market Trends
12. Market Segmentation
13. Volume Analysis
13.1 POC Test
OTC Tests
Professional Tests
Volume Analysis of POC Tests
Volume Trends
13.2 Core Laboratory Test
Key Segmentation
Clinical Chemistry
Immunoassay
Volume Analysis of Core Laboratory Tests
Volume Trends
13.3 Molecular Test
Key Segmentation
Infectious Diseases
Oncology
Inherited Diseases
Other Tests
Volume Analysis of Molecular Test
Volume Trends
13.4 Haematology Test
Volume Analysis by Test Type
Volume Trends
13.5 Coagulation Test
Key Segmentation
International Normalized Ratio
Activated Thromboplastin Time
Volume Analysis by Test Type
Volume Trends
13.6 Microbiology Test
Key Segmentation
Automated Panels and Reagents
Blood Culture
Chromogenic Media
Manual Panels and Reagents
Volume Analysis by Test Type
Volume Trends
13.7 Blood Banking Test
Volume Analysis by Test Type
Volume Trends
13.8 Histology/Cytology Test
Key Segmentation
Pap Stains
Non-pap Stains
Image Cytometry
Flow Cytometry
IHC and ISH
Circulating Tumour Cells
Volume Analysis by Test Type
Volume Trends
14. Pricing Analysis
14.1 POC Test
Market Overview
Major Products
Pricing Trends
14.2 Core Laboratory Test
Market Overview
Major Products
Pricing Trends
14.3 Molecular Test
Market Overview
Major Products
Pricing Trends
14.4 Haematology Test
Market Overview
Major Products
Pricing Trends
14.5 Coagulation Test
Market Overview
Major Products
Pricing Trends
14.6 Microbiology Test
Market Overview
Major Products
Pricing Trends
14.7 Blood Banking Test
Market Overview
Major Products
Pricing Trends
14.8 Histology/Cytology Test
Market Overview
Major Products
Pricing Trends
15. Geographical Segmentation
16. Key Leading Countries
US
Germany
Japan
17. Vendor Landscape by Sales
18. Vendor Landscape by Volume
19. Buying Criteria
20. Key Vendor Analysis
20.1 Abbott Laboratories
Business Overview
Key Information
SWOT Analysis
20.2 Becton Dickinson and Company
Business Overview
Key Information
SWOT Analysis
20.3 bioMerieux SA
Business Overview
Key Information
SWOT Analysis
20.4 F. Hoffmann-La Roche Ltd.
Business Overview
Key Information
SWOT Analysis
20.5 Siemens Healthcare
Business Overview
Key Information
SWOT Analysis
21. Other Reports in this Series




List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global IVD Products and Test Market by Sales 2012-2016 (US$ million)
Exhibit 3: Global IVD Products and Test Market by Volume 2012-2016 (in million units)
Exhibit 4: Global IVD Products and Test Market by Category Segmentation
Exhibit 5: Global IVD Products and Test Market Sales by Category Segmentation 2012
Exhibit 6: Global IVD Products and Test Market Sales by Category Segmentation 2012-2016
Exhibit 7: Global IVD Products and Test Market Volume by Category Segmentation 2012
Exhibit 8: Global IVD Products and Test Market Volume by Category Segmentation 2016-2016
Exhibit 9: POC Test Procedure by Category Segmentation
Exhibit 10: POC Test Procedure Volume by Category Segmentation 2012
Exhibit 11: Global Procedure Volume of OTC Tests 2012-2016 (in million units)
Exhibit 12: OTC Test Procedure Volume by Category Segmentation 2012
Exhibit 13: Global OTC Test Sales 2012-2016 (in US$ million)
Exhibit 14: Global OTC Test Sales by Category Segmentation 2012
Exhibit 15: Global Procedure Volume of Glucose Tests 2012-2016 (in million units)
Exhibit 16: Global Glucose Test Sales 2012-2016 (in US$ million)
Exhibit 17: Global Procedure Volume of Pregnancy/Ovulation Tests 2012-2016 (in million units)
Exhibit 18: Global Pregnancy/Ovulation Test Sales 2012-2016 (in US$ million)
Exhibit 19: Global Procedure Volume of Other Tests 2012-2016 (in million units)
Exhibit 20: Global Other Test Sales 2012-2016 (in US$ million)
Exhibit 21: Global Procedure Volume of Professional Tests 2012-2016 (in millions units)
Exhibit 22: Professional Test Procedure Volume by Category Segmentation 2012
Exhibit 23: Global Professional Test Sales 2012-2016 (in US$ million)
Exhibit 24: Global Professional Test Sales by Category Segmentation 2012
Exhibit 25: Global Procedure Volume of Glucose Tests 2012-2016 (in million units)
Exhibit 26: Global Glucose Test Sales 2012-2016 (in US$ million)
Exhibit 27: Global Procedure Volume of Infectious Disease Tests 2012-2016 (in million units)
Exhibit 28: Global Infectious Disease Test Sales 2012-2016 (in US$ million)
Exhibit 29: Global Procedure Volume of Critical Care Tests 2012-2016 (in million units)
Exhibit 30: Global Critical Care Test Sales 2012-2016 (in US$ million)
Exhibit 31: Global Procedure Volume of Other Tests 2012-2016 (in millions)
Exhibit 32: Global Other Test Sales 2012-2016 (in US$ million)
Exhibit 33: Global Procedure Volume of POC Tests 2012-2016 (in million units)
Exhibit 34: Core Laboratory Test Procedure by Category Segmentation
Exhibit 35: Core Laboratory Test Procedure Volume by Category Segmentation 2012
Exhibit 36: Global Procedure Volume of Clinical Chemistry Test 2012-2016 (in million units)
Exhibit 37: Clinical Chemistry Test Procedure Volume by Category Segmentation 2012
Exhibit 38: Global Clinical Chemistry Test Sales 2012-2016 (in US$ million)
Exhibit 39: Global Clinical Chemistry Test Sales by Category Segmentation 2012
Exhibit 40: Global Procedure Volume of General Chemistry Test 2012-2016 (in millions units)
Exhibit 41: Global General Chemistry Test Sales 2012-2016 (in US$ million)
Exhibit 42: Global Procedure Volume of Blood Gas Analysis 2012-2016 (in million units)
Exhibit 43: Global Blood Gas Analysis Sales 2012-2016 (in US$ million)
Exhibit 44: Global Procedure Volume of Urinalysis 2012-2016 (in million units)
Exhibit 45: Global Urinalysis Sales 2012-2016 (in US$ million)
Exhibit 46: Global Procedure Volume of Immunoassay 2012-2016 (in million units)
Exhibit 47: Immunoassay Procedure Volume by Category Segmentation 2012
Exhibit 48: Global Immunoassay Sales 2012-2016 (in US$ million)
Exhibit 49: Global Immunoassay Sales by Category Segmentation 2012
Exhibit 50: Global Procedure Volume of Infectious Disease Tests 2012-2016 (in million units)
Exhibit 51: Global Infectious Disease Test Sales 2012-2016 (in US$ million)
Exhibit 52: Global Procedure Volume of Cardiac Markers 2012-2016 (in million units)
Exhibit 53: Global Cardiac Marker Sales 2012-2016 (in US$ million)
Exhibit 54: Global Procedure Volume of Tumour Markers 2012-2016 (in million units)
Exhibit 55: Global Tumour Marker Sales 2012-2016 (in US$ million)
Exhibit 56: Global Procedure Volume of Diabetes Tests 2012-2016 (in million units)
Exhibit 57: Global Diabetes Test Sales 2012-2016 (in US$ million)
Exhibit 58: Global Procedure Volume of Autoimmune Disease Tests 2012-2016 (in million units)
Exhibit 59: Global Autoimmune Disease Test Sales 2012-2016 (in US$ million)
Exhibit 60: Global Procedure Volume of Other Tests 2012-2016 (in million units)
Exhibit 61: Global Other Tests Sales 2012-2016 (in US$ million)
Exhibit 62: Global Procedure Volume of Core Laboratory Tests 2012-2016 (in millions)
Exhibit 63: Molecular Test Procedure by Category Segmentation
Exhibit 64: Molecular Test Procedure Volume by Category Segmentation 2012
Exhibit 65: Global Procedure Volume of Infectious Disease Tests 2012-2016 (in millions)
Exhibit 66: Global Infectious Disease Test Sales 2012-2016 (in US$ million)
Exhibit 67: Global Procedure Volume of Oncology Tests 2012-2016 (in millions)
Exhibit 68: Global Oncology Test Sales 2012-2016 (in US$ million)
Exhibit 69: Global Procedure Volume of Inherited Disease Tests 2012-2016 (in million units)
Exhibit 70: Global Inherited Disease Test Sales 2012-2016 (in US$ million)
Exhibit 71: Global Procedure Volume of Other Tests 2012-2016 (in million units)
Exhibit 72: Global Other Test Sales 2012-2016 (in US$ million)
Exhibit 73: Global Procedure Volume of Molecular Test 2012-2016 (in millions)
Exhibit 74: Global Procedure Volume of Haematology Test 2012-2016 (in million units)
Exhibit 75: Coagulation Test Procedure by Category Segmentation
Exhibit 76: Global Procedure Volume of Coagulation Test 2012-2016 (in millions)
Exhibit 77: Microbiology Test Procedure by Category Segmentation
Exhibit 78: Microbiology Test Procedure Volume by Category Segmentation 2012
Exhibit 79: Global Procedure Volume of Automated Panels and Reagents 2012-2016 (in millions)
Exhibit 80: Global Automated Panels and Reagents Sales 2012-2016 (in US$ million)
Exhibit 81: Global Procedure Volume of Blood Culture 2012-2016 (in million units)
Exhibit 82: Global Blood Culture Sales 2012-2016 (in US$ million)
Exhibit 83: Global Procedure Volume of Chromogenic Media Test 2012-2016 (in million units)
Exhibit 84: Global Chromogenic Media Test Sales 2012-2016 (in US$ million)
Exhibit 85: Global Procedure Volume of Manual Panels and Reagents 2012-2016 (in million units)
Exhibit 86: Global Manual Panels and Reagents Sales 2012-2016 (in US$ million)
Exhibit 87: Global Procedure Volume of Microbiology Test 2012-2016 (in millions)
Exhibit 88: Global Procedure Volume of Blood Banking Tests 2012-2016 (in million units)
Exhibit 89: Histology/Cytology Test Procedure by Category Segmentation
Exhibit 90: Histology/Cytology Test Procedure Volume by Category Segmentation 2012
Exhibit 91: Global Procedure Volume of Pap Stains 2012-2016 (in million units)
Exhibit 92: Global Pap Stains Sales 2012-2016 (in US$ million)
Exhibit 93: Global Procedure Volume of Non-pap Stains 2012-2016 (in million units)
Exhibit 94: Global Non-pap Stains Sales 2012-2016 (in US$ million)
Exhibit 95: Global Procedure Volume of Image Cytometry 2012-2016 (in million units)
Exhibit 96: Global Image Cytometry Sales 2012-2016 (in US$ million)
Exhibit 97: Global Procedure Volume of Flow Cytometry 2012-2016 (in million units)
Exhibit 98: Global Flow Cytometry Sales 2012-2016 (in US$ million)
Exhibit 99: Global Procedure Volume of IHC Tests 2012-2016 (in million units)
Exhibit 100: Global IHC Test Sales 2012-2016 (in US$ million)
Exhibit 101: Global Procedure Volume of ISH Tests 2012-2016 (in million units)
Exhibit 102: Global ISH Test Sales 2012-2016 (in US$ million)
Exhibit 103: Global Procedure Volume of CTC Tests 2012-2016 (in million units)
Exhibit 104: Global CTC Test Sales 2012-2016 (in US$ million)
Exhibit 105: Global Procedure Volume of Histology/Cytology Test 2012-2016 (in million units)
Exhibit 106: Global POC Test Sales 2012-2016 (in US$ million)
Exhibit 107: Global POC Test Sales by Category Segmentation 2012
Exhibit 108: Global Core Laboratory Test Sales 2012-2016 (in US$ million)
Exhibit 109: Global Core Laboratory Test Sales by Category Segmentation 2012
Exhibit 110: Global Molecular Test Sales 2012-2016 (in US$ million)
Exhibit 111: Global Molecular Test Sales by Category Segmentation 2012
Exhibit 112: Global Haematology Test Sales 2012-2016 (in US$ million)
Exhibit 113: Global Coagulation Test Sales 2012-2016 (in US$ million)
Exhibit 114: Global Microbiology Test Sales 2012-2016 (in US$ million)
Exhibit 115: Global Microbiology Test Sales by Category Segmentation 2012
Exhibit 116: Global Blood Banking Test Sales 2012-2016 (in US$ million)
Exhibit 117: Global Histology/Cytology Test Sales 2012-2016 (in US$ million)
Exhibit 118: Global Histology/Cytology Test Sales by Category Segmentation 2012
Exhibit 119: Global IVD Products and Test Market by Geographical Segmentation 2012
Exhibit 120: Vendor Segmentation of Global IVD Products and Test Market by Sales 2012
Exhibit 121: Vendor Segmentation of Global IVD Products and Test Market by Volume 2012
Exhibit 122: Business Segmentation of Abbott Laboratories
Exhibit 123: Business Segmentation of Becton Dickinson and Company
Exhibit 124: Business Segmentation of bioMerieux SA
Exhibit 125: Business Segmentation of Hoffmann-La Roche Ltd.
Exhibit 126: Business Segmentation of Siemens Healthcare






Companies Mentioned

Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, F. Hoffmann-La Roche Ltd., Siemens Healthcare, 23andMe Inc., A. Menarini Diagnostics S.r.l., Affymetrix Inc., Agilent Technologies Inc., Alere Inc., ARKRAY Inc., Arrayit Diagnostics Inc, Astra Biotech GmbH, Axis-Shield plc, Beckman Coulter Inc., BG Medicine Inc., Bio-Rad Laboratories Inc., Bruker BioSciences Corp., Caliper Life Sciences Inc., Celera Diagnostics LLC, Cepheid Inc., China Medical Technologies Inc., Dako A/S, Danaher Corp., DiaSorin S.p.A., Eiken Chemical Co. Ltd., ELITech SA, Enzo Biochem Inc., Epigenomics AG, Fujirebio Diagnostics Inc., GE Healthcare, Grifols SA, Horiba Ltd., Idaho Technology Inc., Illumina Inc., Innogenetics NV, Instrumentation Laboratory Company, International Technidyne Corp., Intrinsic Bioprobes Inc., IRIS International Inc., Life Technologies Corp., Linkage Biosciences Inc., Luminex Corp., Magellan Biosciences Inc., Millipore Corp., Mitsubishi Chemical Medience Corp., Nanosphere Inc., Nanosphere Inc., Nova Biomedical Corp., Novartis AG, OPTI Medical Systems Inc., OptiGene Ltd., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Phadia AB, Polymedco Inc., QIAGEN N.V., Quidel Corp., Radient Pharmaceuticals Corp., Radiometer A/S, Randox Laboratories Ltd., Seegene Inc., SensiGen LLC, Sequenom Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Spartan Bioscience Inc., Sysmex Corp., TessArae LLC, Thermo Fisher Scientific Inc., Tosoh Corp., Transasia Bio-Medicals Ltd., Transgenomic Inc., TrimGen Corp., Trinity Biotech plc, TrovaGene Inc., Ventana Medical Systems Inc., Veridex LLC, Vermillion Inc., Wako Pure Chemical Industries Ltd., and Werfen Life Group SA.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.